MedTrace Logo

Training Intervention in the Treatment of Anorexia Nervosa

NCT04185727 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2021-02-26

No results posted yet for this study

Summary

The scope of the STRONG\_2 project is to investigate the effect of supervised exercise as add-on to standard of care (SOC), for patients with eating disorders (EDs). The effect of supervised strength training will be measured on health parameters such as muscle strength. The study includes patients diagnosed with anorexia nervosa and in treatment at the Mental Health Center Ballerup (PCB) in the Capital Region of Denmark.

Conditions

  • Anorexia Nervosa
  • Exercise

Interventions

OTHER

Supervised strength training

12 weeks supervised strength training exposure. The study will allocate patients to groups consisting of 4 members who receive strength training for 12 weeks. The strength training program will consist of three weekly supervised strength exercise sessions, each 40-60 min of duration, which starts with a 10 min warm-up and are completed with a meditation/relax session.

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • University of South-Eastern Norway

    collaborator OTHER

  • Mental Health Services in the Capital Region, Denmark

    lead OTHER

Principal Investigators

  • Jan Magnus Sjögren, MD, PhD · Eating disorder unit, Mental Health Services in the Capital Region, Ballerup

  • Louise B Rasmussen, MD, PhD · Mental Health Services in the Capital Region, Ballerup

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-05
Primary Completion
2020-07-01
Completion
2020-07-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04185727 on ClinicalTrials.gov